Target intelligence / Profile preview

Family with sequence similarity 229 member B (FAM229B)

Target
FAM229B
Molecular classification
Other (Uncharacterized protein)
01

Overview

Family with sequence similarity 229 member B (FAM229B) is an uncharacterized human protein encoded by the FAM229B gene, also referenced as C6orf225, LOC619208, or DKFZp586F0922[5][2]. It is classified as a protein-coding gene, with a known paralog FAM229A, and is predicted to have protein-binding capabilities, but its precise molecular function remains unknown[1][6]. There is no evidence that it acts as an enzyme, receptor, channel, transporter, or other classically druggable protein, nor is there any known association with specific diseases or drug interactions. Current gene ontology data indicate no annotated biological pathways or disease roles, and it is not established as a biomarker or therapeutic target[6]. The protein's structure has been predicted computationally, but no experimental structure has been determined[7]. Its expression has been detected in various tissues, but without strong tissue specificity or established functional significance[7][9]. No drugs are known to interact with FAM229B, and no mechanisms of action for therapeutic modulation have been described. There are no documented safety concerns or challenges associated with targeting this protein. Overall, it should be considered a protein of unknown function with minimal characterization to date.

Other names
C6orf225DKFZp586F0922LOC619208protein FAM229BUPF0731 protein C6orf225F229B_HUMAN
02

Biological functions

Other (Unknown; some evidence for protein binding)
03

Disease associations

Other (No confirmed disease association)

Beyond the preview

Go deeper on Family with sequence similarity 229 member B (FAM229B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Family with sequence similarity 229 member B (FAM229B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call